Global Immunodiagnostics Market - Trends

1
Immunodiagnostics Market
Opportunities and Forecasts, 2014 2022
No of Pages 150
Published Date Nov 2016
2
 
IMMUNODIAGNOSTICS MARKET OVERVIEW

• Global Immunodiagnostics Market would reach
  17,836 Million by 2022, growing at a CAGR of
  7.3 from 2016 to 2022, accordingly new report
  published by Allied Market Research.
• Reagents and consumables is expected to dominate
  the world immunodiagnostics market throughout the
  forecast period.
• North America would continue to lead during the
  forecast period, accounting for more than
  one-third share of the world immunodiagnostics
  market in 2015.
• Rise in incidence of infectious diseases one of
  the most common disease burden globally mainly
  drives the market. Growth in baby boomer
  generation with high-risk of targeted diseases
  and increase in adoption of next generation
  immunodiagnostics platform propels the market
  growth.
• Read more on- https//www.alliedmarketresearch.co
  m/immunodiagnostics-market  

3
 
IMMUNODIAGNOSTICS MARKET OVERVIEW

• Rise in focus of the key players toward
  innovative immunodiagnostics technologies (such
  as automated systems, laboratory integrated
  customized system, and point of care testing
  among others), along with the growth in
  immunodiagnostics labs further drives the market
  growth.
• However, stringent government regulations, high
  cost of the sophisticated immunodiagnostics
  testing such as analyzers and assays, reluctance
  to adopt newer technology in emerging economies
  restrain the market growth.
• Infectious diseases (such as hepatitis,
  retrovirus, HIV, dengue fever, malaria, and
  others) is a leading segment in the
  immunodiagnostics application market accounted
  for over one-fifth of total share in 2015.
• Owing to diversified use of immunodiagnostics
  devices in the diagnosis of varied infectious
  diseases with lower risk followed by quick,
  reliable, and high success rate has favored its
  growth in infectious diseases market.

4
 
IMMUNODIAGNOSTICS MARKET KEY FINDINGS

• In 2015, reagents and consumables was the leading
  product type, and is projected to grow at a CAGR
  of 8.1 during the forecast period.
• CLIA is expected to grow at a remarkable CAGR of
  8.0, owing to the non-radioactive nature, high
  sensitivity, and simple equipment designed for
  well-equipped clinical laboratories.
• Oncology endocrinology application is projected
  to grow at a high CAGR of 8.1 during the
  analysis period.
• U.S. alone contributes over three-fourth market
  share in the North America region of
  immunodiagnostics market in 2015.
• China is the major shareholder in the
  Asia-Pacific region accounting for around
  one-third of the Asia-Pacific immunodiagnostics
  market.
• North America is expected to dominate the
  immunodiagnostics market followed by Europe,
  during the analysis period.

5
 
KEY BENEFITS OF IMMUNODIAGNOSTICS MARKET

• The study provides an in-depth analysis of the
  global immunodiagnostics market with current
  trends and future estimations to elucidate the
  imminent investment pockets.
• The report provides a quantitative analysis from
  2014 to 2022 to enable the stakeholders to
  capitalize on prevailing market opportunities.
• Competitive intelligence highlights the business
  practices followed by leading market players
  across various geographic regions.
• Porters Five Forces model will interpret the
  bargaining power of suppliers and buyers, threat
  of new entrants and substitutes, and competition
  amongst the key players.
• Extensive analysis is conducted by following key
  product positioning and monitoring the top
  competitors within the market framework.

6
 
KEY PLAYERS IN INDUSTRY

• Abbott Laboratories
• Immunodiagnostic Systems Holdings Plc (IDS)
• DiaSorin S.p.A.
• Johnson Johnson
• F. Hoffmann-La Roche Ltd
• Siemens AG
• Sysmex Corporation
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Arkray Inc.
• Get sample report at- https//www.alliedmarketres
  earch.com/request-free-sample/1763

7
 
KEY DRIVERS OF IMMUNODIAGNOSTICS MARKET
8
 
IMMUNODIAGNOSTICS MARKET SEGMENTATION
9
 
IMMUNODIAGNOSTICS MARKET BY REGION

• North America, Europe, Asia-Pacific, LAMEA

10
 
DEFIBRILLATORS MARKET
Enzyme-Linked Immunosorbent Assay (ELISA) is
highly preferred technology due to its minimal
invasive nature and is designated as -gold
standard of clinical immunodiagnostics modality
for diagnosing various diseases. Despite numerous
advancement in the immunodiagnostics field, ELISA
will maintain lead due to its high precision,
sensitivity, specificity, and throughput as
compared to others at economical cost.  Garima
Chandra
11
 
 
Thank You! For More Details
Visit us at
https//www.alliedmarketresearch.com/immunodiagnos
tics-market
Follow Us On